Lung Adenosquamous Carcinoma Arising From a Long-Standing Bronchogenic Cyst
This lung cancer diagnosis at a glance
- Biomarkers
- KRAS G12D mutation; PD-L1 TPS 60%; EGFR/BRAF/ROS1/ALK negative
- Sex
- female
- Treatment
- surgery, chemotherapy and immunotherapy
- Outcome
- Cancer-Free / NED
Treatment course, step by step
- Underwent left lower lobectomy with mediastinal lymph-node dissection.
- Received 4 cycles of cisplatin and docetaxel.
- Received 2 cycles of atezolizumab before immunotherapy was stopped because of immune-mediated colitis.
What happened, in summary
A 74-year-old woman who had never smoked had lived with an intrapulmonary bronchogenic cyst since age 15. The cyst had been stable for decades, but routine follow-up eventually showed that it had enlarged and developed a solid component. Persistent low sodium levels also prompted further investigation.
A needle sample showed both glandular and squamous cancer features. Molecular testing found a KRAS G12D mutation, and PD-L1 expression was high at 60%. Testing for EGFR, BRAF, ROS1, and ALK alterations was negative. PET/CT showed a suspicious nearby lymph node, but sampling of mediastinal nodes did not find cancer.
She underwent left lower lobectomy with mediastinal lymph-node dissection. The surgical specimen confirmed adenosquamous carcinoma arising directly beside the long-standing bronchogenic cyst, with transition from the benign cyst lining into the malignant tumor. Twenty-two regional lymph nodes were negative.
After surgery, she received 4 cycles of cisplatin and docetaxel followed by 2 cycles of atezolizumab. Immunotherapy had to be stopped because she developed immune-mediated colitis. Despite this complication, she remained in remission 2.4 years after surgery. The malignant transformation occurred only after the cyst changed at age 74, so the decades-long history belonged to the benign cyst rather than to the lung cancer.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- KRAS Mutation Lung Cancer 20 stories
- Atezolizumab for Lung Cancer 18 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer